853 results on '"Cruz-Correa, Marcia"'
Search Results
52. Abstract 995: Evaluation of plasma cytokines and chemokines as potential biomarkers for colorectal cancer detection
53. 108 Pilot Project Awardees Productivity Award Metrics at The Alliance Idea-CTR
54. Supplementary Figure 1 from Hypoxia-Inducible Factor-1 Target Genes as Indicators of Tumor Vessel Response to Vascular Endothelial Growth Factor Inhibition
55. Data from Hypoxia-Inducible Factor-1 Target Genes as Indicators of Tumor Vessel Response to Vascular Endothelial Growth Factor Inhibition
56. Randomized, Double-Blind, Placebo-Controlled Trial of MUC1 Peptide Vaccine for Prevention of Recurrent Colorectal Adenoma
57. Abstract P1-06-07: Interrogating the Molecular Profile of Breast Cancer Tumors in Hispanics Living in Puerto Rico (PRH)
58. Risk of Colorectal and Other Cancers in Patients With Serrated Polyposis
59. Type 2 diabetes mellitus and colorectal neoplasia risk in Hispanics: a case–control study
60. Metformin Does Not Reduce Markers of Cell Proliferation in Esophageal Tissues of Patients With Barrett’s Esophagus
61. Clinical Cancer Genetics Disparities among Latinos
62. Rationale 305: Phase 3 study of tislelizumab plus chemotherapy vs placebo plus chemotherapy as first-line treatment (1L) of advanced gastric or gastroesophageal junction adenocarcinoma (GC/GEJC).
63. RELATIVITY-106: A phase 1/2 trial of nivolumab (NIVO) + relatlimab (RELA) in combination with bevacizumab (BEV) in first-line (1L) hepatocellular carcinoma (HCC).
64. Loss of IGF2 Imprinting: A Potential Marker of Colorectal Cancer Risk
65. Seroprevalence of Helicobacter pylori in Hispanics living in Puerto Rico: A population‐based study
66. Deciphering colorectal cancer genetics through multi-omic analysis of 100,204 cases and 154,587 controls of European and east Asian ancestries
67. Abstract A016: Successful design and execution of two gastric cancer chemoprevention trials in Central America and Puerto Rico
68. Genetic Approaches to Colorectal Cancer
69. Can the Sum of Adenoma Diameters (Adenoma Bulk) on Index Examination Predict Risk of Metachronous Advanced Neoplasia?
70. Personal Perspective on Mentoring
71. Association of genetic ancestry with colorectal tumor location in Puerto Rican Latinos
72. Neither 10-nor 14-day sequential treatment is better than standard triple therapy for helicobacter pylori eradication
73. The Burden of CRC Among US Hispanics: More Polyps, Less Cancer
74. Risk of thyroid cancer among Caribbean Hispanic patients with familial adenomatous polyposis
75. Randomized, Double-Blind, Placebo-Controlled Trial of MUC1 Peptide Vaccine for Prevention of Recurrent Colorectal Adenoma
76. S1538 Clinicopathologic Characterization and Genotype Correlation of Duodenal Polyposis Among Hispanics With Familial Adenomatous Polyposis
77. Clinical characterization and mutation spectrum in Caribbean Hispanic families with Lynch syndrome
78. A Combination of Esomeprazole and Aspirin Reduces Tissue Concentrations of Prostaglandin E2 in Patients With Barrett's Esophagus
79. Ethnic and Sex Disparities in Colorectal Neoplasia Among Hispanic Patients Undergoing Screening Colonoscopy
80. Racial/ethnic disparities in gastric cancer: A 15‐year population‐based analysis
81. Abstract 1172: Interrogating the molecular profile of breast cancer tumors in US Hispanics
82. Abstract CT246: Phase 1b/2 study of giloralimab in combination with modified FOLFIRINOX with or without budigalimab in patients with untreated metastatic pancreatic cancer
83. Abstract 2266: Host genetic susceptibility to COVID-19 and pandemic -associated stressors
84. Abstract 2183: Interrogating the molecular profile of colorectal cancer: detection of clinically actionable alterations in Hispanics
85. Abstract 3526: Host genetic susceptibility to gut microbiota-driven colorectal carcinogenesis
86. Tumor Molecular Profiling in Hispanics: Moving Towards Precision Oncology and Health Equity
87. Women Gastroenterologists in Academic Medicine: Tradition Versus Transition
88. Rapid Development of Colorectal Neoplasia in Patients With Lynch Syndrome
89. Phase II trial of weekly erlotinib dosing to reduce duodenal polyp burden associated with familial adenomatous polyposis
90. The prevalence of Barrett's esophagus associated dysplasia in Puerto Rico
91. 1145 EVALUATION OF THE SAFETY AND EFFICACY OF EFLORNITHINE (DIFLUOROMETHYLORNITHINE, DFMO) IN PATIENTS WITH GASTRIC PREMALIGNANT CONDITIONS IN THE HIGH INCIDENCE AREAS OF LATIN AMERICA
92. Polyposis syndromes
93. A Trial of Calcium and Vitamin D for the Prevention of Colorectal Adenomas
94. Racial/ethnic disparities in gastric cancer: A 15‐year population‐based analysis.
95. Variation in the Risk of Colorectal Cancer for Lynch Syndrome: A retrospective family cohort study
96. Correlates of colorectal cancer screening among hispanics: results from the 2008 Puerto Rico behavioral risk factor surveillance system survey
97. Clinical characterization and mutation spectrum in Hispanic families with adenomatous polyposis syndromes
98. S1331 Phase II Trial of Weekly Erlotinib Dosing to Reduce Duodenal Polyp Burden Associated With Familial Adenomatous Polyposis
99. A new phenotypic manifestation of familial adenomatous polyposis
100. Occurrence of Colorectal Adenomas in Younger Adults: An Epidemiologic Necropsy Study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.